HSV-1 PROCESSING AND PACKAGING GENES
HSV-1 加工和包装基因
基本信息
- 批准号:2390419
- 负责人:
- 金额:$ 16.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-04-01 至 2000-03-31
- 项目状态:已结题
- 来源:
- 关键词:Baculoviridae antiserum capsid confocal scanning microscopy genetic recombination herpes simplex virus 1 immunofluorescence technique immunoprecipitation monoclonal antibody mutant nuclease protein biosynthesis protein structure function recombinant DNA tissue /cell culture transfection /expression vector virion virus DNA virus assembly virus genetics virus protein
项目摘要
Herpes simplex viruses are endemic in the population and are responsible
for a variety of clinical diseases some of which are life threatening,
especially in immunocompromised individuals or in newborns. The herpes
simplex virus type-1 (HSV-1) genome contains three origins of replication
and encodes seven viral genes that are essential for viral genome
replication in vivo. However actual mode of viral DNA replication and the
role of recombination in this process are not well understood. Even less
well understood are the processes of viral genome maturation and
encapsidation. The objective of this proposal is to provide a better
understanding of the events of genome processing and packaging through the
genetic and biochemical analysis of seven viral genes that have been
implicated in these processes. Preliminary evidence indicates that UL12,
alkaline nuclease, plays an important role in genome maturation and
encapsidation. Null mutants in UL12 synthesize viral DNA and initiate
cleavage and packaging events; however, the DNA containing capsids which
accumulate in the nucleus do not mature into the cytoplasm. The other six
viral genes under study (UL6, UL15, UL25, UL28, UL32 and UL33) have been
implicated in genome cleavage and packaging at a different stage. Mutants
in each of these genes have a common phenotype: they are able to carry out
viral DNA synthesis but are unable to cleave or package viral genomes when
grown under nonpermissive conditions.
The first aim is to generate the necessary reagents to carry out the
subsequent aims; these include constructs for the expression of each
protein in a variety of expression systems and the generation of and
characterization of specific antisera. The second aim is to isolate or
further characterize null mutants in each gene. Most of the existing
mutants in these genes for both HSV and pseudorabies (PRV) are temperature
sensitive (ts); however, because of potential difficulties with ts mutants
such as leak and interference with the function of wild type alleles, it
is important to isolate effective null mutants in each gene. The third aim
is to establish the location of the putative processing/packaging genes
within virions and within infected cells. Specifically we plan to use
indirect immunofluorescence and confocal microscopy to characterize the
intracellular localization both with respect to each other and with
respect to replication and capsid protein complexes. In the fourth aim
putative protein-protein interactions between the seven proteins will be
analyzed by biochemical and genetic methods. Long term aims include
assaying each putative processing/packaging protein for predicted
activities such as ATPase, terminase, and DNA binding and carrying out a
detailed structure-function analysis of each gene. It is anticipated that
an analysis of the processing/packaging proteins will not only provide an
understanding of the mechanisms of their action but may also lead to the
development of novel strategies for antiviral therapy.
单纯疱疹病毒在人群中流行并造成
对于多种临床疾病,其中一些是危及生命的,
尤其是免疫功能低下的个体或新生儿。疱疹
1 型单纯病毒 (HSV-1) 基因组包含三个复制起点
并编码病毒基因组必需的七个病毒基因
体内复制。然而病毒DNA复制的实际模式和
重组在此过程中的作用尚不清楚。甚至更少
病毒基因组成熟的过程已广为人知
衣壳化。该提案的目的是提供更好的
通过以下方式了解基因组加工和包装的事件
对七种病毒基因进行遗传和生化分析
参与这些过程。初步证据表明 UL12,
碱性核酸酶在基因组成熟和
衣壳化。 UL12 中的无效突变体合成病毒 DNA 并启动
裂解和包装事件;然而,含有衣壳的DNA
积累在细胞核中,不成熟进入细胞质。其他六个
正在研究的病毒基因(UL6、UL15、UL25、UL28、UL32 和 UL33)已被
涉及不同阶段的基因组切割和包装。突变体
这些基因中的每一个都有一个共同的表型:它们能够执行
病毒 DNA 合成,但无法切割或包装病毒基因组
在非许可条件下生长。
第一个目标是产生必要的试剂来进行
后续目标;这些包括每个表达的构建体
多种表达系统中的蛋白质以及
特定抗血清的表征。第二个目标是隔离或
进一步表征每个基因中的无效突变体。现有的大部分
HSV 和伪狂犬病 (PRV) 这些基因的突变体是温度
敏感(ts);然而,由于 ts 突变体的潜在困难
例如泄漏和干扰野生型等位基因的功能,
对于分离每个基因中有效的无效突变体非常重要。第三个目标
是确定假定的加工/包装基因的位置
在病毒粒子内和受感染的细胞内。具体来说,我们计划使用
间接免疫荧光和共聚焦显微镜来表征
细胞内定位既相互相关又与
关于复制和衣壳蛋白复合物。在第四个目标中
七种蛋白质之间假定的蛋白质-蛋白质相互作用将是
通过生化和遗传学方法进行分析。长期目标包括
分析每个假定的加工/包装蛋白以预测
ATP 酶、终止酶和 DNA 结合等活动
每个基因的详细结构功能分析。预计
对加工/包装蛋白质的分析不仅可以提供
了解其作用机制,但也可能导致
开发新的抗病毒治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANDRA K WELLER其他文献
SANDRA K WELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANDRA K WELLER', 18)}}的其他基金
Exploring herpesvirus exonucleases as potential antiviral targets
探索疱疹病毒核酸外切酶作为潜在的抗病毒靶点
- 批准号:
10825475 - 财政年份:2023
- 资助金额:
$ 16.28万 - 项目类别:
Exploring the Coronavirus Exoribonuclease as an Antiviral Target
探索冠状病毒外核糖核酸酶作为抗病毒靶点
- 批准号:
10238324 - 财政年份:2021
- 资助金额:
$ 16.28万 - 项目类别:
New faculty recruitment in NMR structural biology
核磁共振结构生物学新教师招聘
- 批准号:
7857166 - 财政年份:2009
- 资助金额:
$ 16.28万 - 项目类别:
New faculty recruitment in NMR structural biology
核磁共振结构生物学新教师招聘
- 批准号:
7944151 - 财政年份:2009
- 资助金额:
$ 16.28万 - 项目类别:
ASM Conference on Manipulation of Nuclear Processes by DNA Viruses
ASM DNA 病毒操纵核过程会议
- 批准号:
7485476 - 财政年份:2008
- 资助金额:
$ 16.28万 - 项目类别:
Role of viral and cellular recombination proteins in HSV DNA replication
病毒和细胞重组蛋白在 HSV DNA 复制中的作用
- 批准号:
7548622 - 财政年份:2006
- 资助金额:
$ 16.28万 - 项目类别:
Role of viral and cellular recombination proteins in HSV DNA replication
病毒和细胞重组蛋白在 HSV DNA 复制中的作用
- 批准号:
8610869 - 财政年份:2006
- 资助金额:
$ 16.28万 - 项目类别:
Role of viral and cellular recombination proteins in HSV DNA replication
病毒和细胞重组蛋白在 HSV DNA 复制中的作用
- 批准号:
8438424 - 财政年份:2006
- 资助金额:
$ 16.28万 - 项目类别:
Role of viral and cellular recombination proteins in HSV DNA replication
病毒和细胞重组蛋白在 HSV DNA 复制中的作用
- 批准号:
7079573 - 财政年份:2006
- 资助金额:
$ 16.28万 - 项目类别:
相似海外基金
The Treatment of Pneumonia with Antiserum 1892-1942
抗血清治疗肺炎 1892-1942
- 批准号:
6528417 - 财政年份:2001
- 资助金额:
$ 16.28万 - 项目类别:
The Treatment of Pneumonia with Antiserum 1892-1942
抗血清治疗肺炎 1892-1942
- 批准号:
6417256 - 财政年份:2001
- 资助金额:
$ 16.28万 - 项目类别:
Detection of the activation of caspases during neuronal cell death by using antiserum specifically recognizing active form of caspases
使用特异性识别半胱天冬酶活性形式的抗血清检测神经元细胞死亡过程中半胱天冬酶的激活
- 批准号:
11480235 - 财政年份:1999
- 资助金额:
$ 16.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Production of antiserum against pyrogenic factor and pyrogenic mechanisms using the antiserum.
抗致热因子抗血清的生产以及使用该抗血清的致热机制。
- 批准号:
61570086 - 财政年份:1986
- 资助金额:
$ 16.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
GENERATION OF ANTISERUM TO PDGF SYNTHETIC PEPTIDES
PDGF 合成肽抗血清的产生
- 批准号:
3425103 - 财政年份:1986
- 资助金额:
$ 16.28万 - 项目类别:
CYTOSKELETON-MEMBRANE INTERACTIONS--ANTISERUM INDUCED C
细胞骨架-膜相互作用--抗血清诱导的 C
- 批准号:
3182784 - 财政年份:1985
- 资助金额:
$ 16.28万 - 项目类别:
CYTOSKELETON-MEMBRANE INTERACTIONS--ANTISERUM INDUCED C
细胞骨架-膜相互作用--抗血清诱导的 C
- 批准号:
3182781 - 财政年份:1985
- 资助金额:
$ 16.28万 - 项目类别: